CRISPR THERAPEUTICS AG Weighted Average Number of Shares Outstanding, Basic and Diluted
CRISPR THERAPEUTICS AG (CRSP) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 61.42 million shares for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-07-27.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2020-07-27
- CRISPR THERAPEUTICS AG weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 61.42M shares, a 15.48% increase year-over-year.
- CRISPR THERAPEUTICS AG weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-03-31 was 60.85M shares, a 16.81% increase year-over-year.
- CRISPR THERAPEUTICS AG weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-06-30 was 53.19M shares, a 13.55% increase year-over-year.
- CRISPR THERAPEUTICS AG weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-03-31 was 52.09M shares, a 13.55% increase year-over-year.
- CRISPR THERAPEUTICS AG weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 47.96M shares, a 19.74% increase from fiscal 2017.
- CRISPR THERAPEUTICS AG weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 40.06M shares, a 226.80% increase from fiscal 2016.
- CRISPR THERAPEUTICS AG weighted average number of shares outstanding, basic and diluted for fiscal 2016 was 12.26M shares, a 143.33% increase from fiscal 2015.
- CRISPR THERAPEUTICS AG weighted average number of shares outstanding, basic and diluted for fiscal 2015 was 5.04M shares, a 41.50% increase from fiscal 2014.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-06-30 | 61.42M shares 10-Q · filed 2020-07-27 | 61.13M shares 10-Q · filed 2020-07-27 | ||
| 2020-03-31 | 60.85M shares 10-Q · filed 2020-04-28 | |||
| 2019-06-30 | 53.19M shares 10-Q · filed 2020-07-27 | 52.64M shares 10-Q · filed 2020-07-27 | 52.34M shares derived: average of 3 quarters · filed 2020-07-27 | 51.10M shares derived: average of 4 quarters · filed 2020-07-27 |
| 2019-03-31 | 52.09M shares 10-Q · filed 2020-04-28 | 51.91M shares derived: average of 2 quarters · filed 2020-04-28 | 50.40M shares derived: average of 3 quarters · filed 2020-04-28 | 49.51M shares derived: average of 4 quarters · filed 2020-04-28 |
| 2018-12-31 | 51.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | 49.56M shares derived: average of 2 quarters · filed 2019-02-25 | 48.65M shares derived: average of 3 quarters · filed 2019-07-29 | 47.96M shares 10-K · filed 2019-02-25 |
| 2018-09-30 | 47.39M shares 10-Q · filed 2018-11-07 | 47.12M shares derived: average of 2 quarters · filed 2019-07-29 | 46.71M shares 10-Q · filed 2018-11-07 | 45.16M shares derived: average of 4 quarters · filed 2019-07-29 |
| 2018-06-30 | 46.84M shares 10-Q · filed 2019-07-29 | 46.36M shares 10-Q · filed 2019-07-29 | 44.41M shares derived: average of 3 quarters · filed 2019-07-29 | 43.33M shares derived: average of 4 quarters · filed 2019-07-29 |
| 2018-03-31 | 45.88M shares 10-Q · filed 2019-04-29 | 43.20M shares derived: average of 2 quarters · filed 2019-04-29 | 42.16M shares derived: average of 3 quarters · filed 2019-04-29 | 41.59M shares derived: average of 4 quarters · filed 2019-04-29 |
| 2017-12-31 | 40.51M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | 40.30M shares derived: average of 2 quarters · filed 2019-02-25 | 40.17M shares derived: average of 3 quarters · filed 2019-02-25 | 40.06M shares 10-K · filed 2019-02-25 |
| 2017-09-30 | 40.09M shares 10-Q · filed 2018-11-07 | 39.99M shares derived: average of 2 quarters · filed 2018-11-07 | 39.90M shares 10-Q · filed 2018-11-07 | 38.12M shares derived: average of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | 39.90M shares 10-Q · filed 2018-08-07 | 39.81M shares 10-Q · filed 2018-08-07 | 37.46M shares derived: average of 3 quarters · filed 2019-02-25 | 29.42M shares derived: average of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | 39.73M shares 10-Q · filed 2018-05-08 | 36.24M shares derived: average of 2 quarters · filed 2019-02-25 | 25.93M shares derived: average of 3 quarters · filed 2019-02-25 | 20.81M shares derived: average of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | 32.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | 19.03M shares derived: average of 2 quarters · filed 2019-02-25 | 14.50M shares derived: average of 3 quarters · filed 2019-02-25 | 12.26M shares 10-K · filed 2019-02-25 |
| 2016-09-30 | 5.29M shares 10-Q · filed 2017-11-08 | 5.37M shares derived: average of 2 quarters · filed 2017-11-08 | 5.42M shares 10-Q · filed 2017-11-08 | 5.45M shares derived: average of 4 quarters · filed 2017-11-08 |
| 2016-06-30 | 5.45M shares 10-Q · filed 2017-08-10 | 5.49M shares 10-Q · filed 2017-08-10 | 5.50M shares derived: average of 3 quarters · filed 2017-08-10 | 5.51M shares derived: average of 4 quarters · filed 2017-08-10 |
| 2016-03-31 | 5.53M shares 10-Q · filed 2017-05-11 | 5.53M shares derived: average of 2 quarters · filed 2017-05-11 | 5.53M shares derived: average of 3 quarters · filed 2017-05-11 | 5.28M shares derived: average of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | 5.53M shares 10-K · filed 2017-03-10 | 5.53M shares derived: average of 2 quarters · filed 2017-03-10 | 5.20M shares derived: average of 3 quarters · filed 2017-03-10 | 5.04M shares 10-K · filed 2018-03-08 |
| 2015-09-30 | 5.53M shares 10-K · filed 2017-03-10 | 5.03M shares derived: average of 2 quarters · filed 2017-03-10 | 4.87M shares 10-Q · filed 2016-11-22 | |
| 2015-06-30 | 4.54M shares 10-K · filed 2017-03-10 | 4.05M shares derived: average of 2 quarters · filed 2017-03-10 | ||
| 2015-03-31 | 3.56M shares 10-K · filed 2017-03-10 | |||
| 2014-12-31 | 3.56M shares 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |